Related references
Note: Only part of the references are listed.Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
Anouk E. J. Latenstein et al.
EUROPEAN JOURNAL OF CANCER (2020)
Supramolecular Assemblies of Heterogeneous Mesoporous Silica Nanoparticles to Co-deliver Antimicrobial Peptides and Antibiotics for Synergistic Eradication of Pathogenic Biofilms
Qilin Yu et al.
ACS NANO (2020)
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
Rafael R. Castillo et al.
PHARMACEUTICS (2020)
Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?
Etienne J. Slapak et al.
BIOLOGY-BASEL (2020)
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases
Cheng-Wei Chou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for Self-Actuating On-Demand Controlled Drug Delivery for Cancer Therapy
Kalpesh Vaghasiya et al.
ACS APPLIED BIO MATERIALS (2020)
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
Emily Gobin et al.
BMC CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer
Justin H. Lo et al.
MOLECULAR CANCER THERAPEUTICS (2018)
被撤回的出版物: Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549 (Retracted article. See vol. 17, 2022)
Tieliang Wang et al.
NANOSCALE RESEARCH LETTERS (2017)
Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma
Tetsuya Idichi et al.
ONCOTARGET (2017)
被撤回的出版物: Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549 (Retracted article. See vol. 17, 2022)
Tieliang Wang et al.
NANOSCALE RESEARCH LETTERS (2017)
Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX
Ali McBride et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer
Anna Watermann et al.
NANOMATERIALS (2017)
Overview of transcriptomic analysis of all human proteases, non-proteolytic homologs and inhibitors: Organ, tissue and ovarian cancer cell line expression profiling of the human protease degradome by the CLIP-CHIP™ DNA microarray
Reinhild Kappelhoff et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation and Release of Proteins
Jing Tu et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer
Xiangsheng Liu et al.
ACS NANO (2016)
Tumor-Microenvironment-Adaptive Nanoparticles Codeliver Paclitaxel and siRNA to Inhibit Growth and Lung Metastasis of Breast Cancer
Shan Tang et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
Shouhui Yang et al.
CANCER RESEARCH (2016)
Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow
Barbara Gruenwald et al.
MOLECULAR CANCER RESEARCH (2016)
SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts
Harrison Kim et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
Huan Meng et al.
ACS NANO (2015)
Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to ex Vivo Human and Mouse Lung Tumors
Sabine H. van Rijt et al.
ACS NANO (2015)
Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract
Helene Damhofer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles
Lijue Chen et al.
NANOSCALE (2015)
Mesoporous silica nanoparticles in target drug delivery system: A review
Charu Bharti et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION (2015)
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
Albrecht Neesse et al.
GUT (2014)
Whole Blood Gene Expression Profile Associated with Spontaneous Preterm Birth in Women with Threatened Preterm Labor
Yujing Jan Heng et al.
PLOS ONE (2014)
Multifunctional Envelope-Type Mesoporous Silica Nanoparticles for Tumor-Triggered Targeting Drug Delivery
Jing Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Gelatin-mesoporous silica nanoparticles as matrix metalloproteinases-degradable drug delivery systems in vivo
Jun-Hua Xu et al.
MICROPOROUS AND MESOPOROUS MATERIALS (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Contribution of FKBP5 Genetic Variation to Gemcitabine Treatment and Survival in Pancreatic Adenocarcinoma
Katarzyna A. Ellsworth et al.
PLOS ONE (2013)
Folic Acid-Modified Mesoporous Silica Nanoparticles for Cellular and Nuclear Targeted Drug Delivery
Fabiola Porta et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
Timothy R. Donahue et al.
CLINICAL CANCER RESEARCH (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
Pedro A. Perez-Mancera et al.
NATURE (2012)
Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis
Noa Novershtern et al.
CELL (2011)
Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release
Neetu Singh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Peptide modified mesoporous silica nanocontainers
Fabiola Porta et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2011)
Fluorescent Substrates Useful as High Throughput Screening Tools for ADAM9
Marcia L. Moss et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2010)
Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma
Tine S. Mantoni et al.
CANCER BIOLOGY & THERAPY (2008)
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy
I. Craig Henderson et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release
Brian G. Trewyn et al.
ACCOUNTS OF CHEMICAL RESEARCH (2007)
A distinctive alveolar macrophage activation state induced by cigarette smoking
PG Woodruff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data
AR Abbas et al.
GENES AND IMMUNITY (2005)
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
A Bar-Or et al.
BRAIN (2003)
Share Paper
